GENEVERIFY

Based on the published literature, about 35% of cancer patients that are normal by histology and clinical assessment have, in fact, early stage cancer based on their genetic profile. Our team of scientists at GeneVerify are developing innovative, gene-based testing for early diagnosis, prognosis and monitoring treatment, as well as gene-based treatments for various cancers... At GeneVerify, Inc., we have assembled a highly talented, multi-disciplinary team of molecular biologists, cell biologists, pathologists, biochemists, urologists, surgical oncologists, medical oncologists, radiation oncologists, physicians and surgeons committed every day to meeting the challenges of evolving gene-based diagnosis and treatment of various solid tumors... GeneVerify, Inc., provides in vitro diagnostic reagents for research laboratory-based assays for analysis of sets of these oncogenic protein-coding and non-coding genes in various cancers. Our extensive network of colleagues is committed to..

Also known as: GeneVerify Inc., GeneVerify LLC

Primary location: Hayward United States